Results for "Rothschild & Co Redburn"

Rothschild & Co Redburn has adopted a bearish outlook on FactSet (FDS), citing risks associated with AI and a weakening market position.

Rothschild & Co Redburn has begun its coverage of Celestica Inc. and Ciena Corporation. This marks the initiation of analyst coverage for both companies by the firm.

MoonLake Immunotherapeutics has been upgraded by Rothschild & Co Redburn, with analysts citing the potential for FDA approval of the company's lead drug. This upgrade reflects increased confidence in the drug's market prospects.

Walmart (WMT) has seen its price target boosted by Rothschild & Co Redburn, citing the company's strong digital momentum.

Rothschild & Co Redburn has reaffirmed its 'Buy' rating for S&P Global (SPGI) while slightly reducing its price objective for the company.

Rothschild & Co Redburn has downgraded Insulet Corporation (PODD), citing 'eroding' product moats and distribution as reasons for the revised rating.

Rothschild & Co Redburn has reduced its price target for Delta Air Lines, Inc. (DAL) to $70, reflecting a more cautious outlook for the airline.

Church & Dwight (CHD) has been upgraded by Rothschild & Co Redburn, citing a more attractive valuation for the company's stock.

Rothschild & Co Redburn has maintained a neutral rating on Tradeweb (TW) and issued a new bull rating for Lyft. These ratings reflect the firm's current outlook on the respective companies.

Rothschild & Co Redburn has upgraded McDonald's (MCD) stock, while Morgan Stanley has trimmed its price target for the fast-food giant.

Rothschild & Co Redburn sees shares trading around the flatline in the near future.